March 30, 2022
Dear colleagues,
In addition to the previous message dated March 10, 2022 , I have the pleasure to send
you information about new opportunities for grants offered by Cure Within Reach that
works in the fields of scientific research in the domain of repurposing of drugs and
medical devices for LMICs ( Written in red in the attached message). Hence, this could
lead to new indications and increase opportunities to access medical care.
I wrote a full chapter about drugs and devices repurposing in our new
book “Approaching Global Oncology: The win-win model”, edited by Ahmed
Elzawawy and Wilfred Ngwa. There are more than 100 hundred contributors and the
book is honored with a special contribution of H.E. the late Dr. Tabaré Vázquez,
immediate past president of the republic of Uruguay, A keynote by HRH Princess Dina
Mired and a foreword by Sir Muir Gray.
Dr. Clare Thibodeaux wrote a chapter in this book about opportunities of research for
LMICs in fields of drugs and medical devices.
Please forward the message of Dr. Clare Thibodeaux, Vice President, Scientific Affairs,
Cures Within Reach for all who might be interested.
Kind regards \
Sincerely,
Ahmed
Prof. Ahmed Elzawawy
www.icedoc.net/winwin.htm & www.icedoc.org
---------- Forwarded message ---------
From: Clare Thibodeaux, PhD <
[email protected]>
Date: Wed, Mar 30, 2022 at 3:30 PM
Subject: Research Funding - DEI, Blood Cancer, Rare Disease, Health Disparities, LMIC
To:
[email protected] <
[email protected]>
Dear Ahmed:
Cures Within Reach has open funding opportunities for blood cancers, minority
PIs, health disparities, rare diseases and low and lower-middle income
country (LMIC) PIs. Which one is a fit for you? More info at https://bit.ly/cwrrfps:
• Blood Cancers: Budgets of up to $75,000 for clinical drug repurposing
trials from any institution worldwide; proposal deadline May 6
• Diversity, Equity and Inclusion (DEI), including either clinical trials
impacting racial / ethnic health disparities or clinical trials led by
underrepresented racial / ethnic minority researchers:
o US-based DEI: Budgets of up to $70,000 for clinical repurposing
trials from any US institution to address DEI; proposal deadline
June 6
o Chicago focused DEI: Budgets of up to $100,000 for clinical
repurposing trials in from any Chicago area institution to address
DEI; proposal deadline June 6
• Rare Diseases: Budgets of up to $70,000 for clinical repurposing trials to
address DEI in rare diseases from any US institution, for a Fall
2022 CureAccelerator Live! event; proposal deadline June 6
• ReGRoW for Low and Lower-Middle Income Countries: Budgets of up
to US$50,000 for repurposing clinical trials in any disease led by PIs
based in low and lower-middle income countries; proposal deadline
June 20
There's no limit to the number of submissions accepted from any one researcher
or institution, and researchers at any career stage are welcome to apply.
Submit a proposal today or help us spread the word by sharing these
opportunities at your institution and with your network! To start a proposal, log
into CureAccelerator or sign up as a Researcher or Clinician.
Contact me if you have any questions. Thanks in advance, and we look forward
to hearing from you!
Best,
Clare
Clare Thibodeaux, PhD
Vice President, Scientific Affairs
Cures Within Reach
[email protected]847-745-1250
134 N. LaSalle St, #1130, Chicago IL, 60602
